Regulatory Roundup: Ethics Group Calls on FTC to Investigate Drug Pricing
ePT--the Electronic Newsletter of Pharmaceutical Technology
Ethics Group Calls on FTC to Investigate Drug Pricing
The Citizens for Responsibility and Ethics in Washington, a nonprofit organization dedicated to promoting ethics and accountability, sent a letter to the Federal Trade Commission (FTC) on July 6, 2010, asking for the commission to investigate drug companies “that offer significant discounts to doctors for providing patients with only that company’s vaccines.” The organization claims that Sanofi Pasteur and Merck “offer significant price discounts” if healthcare groups agree to buy their vaccines solely from one manufacturer. The organization states that this practice prevents doctors from using alternative vaccines, even when they may better meet patient needs.
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
Pharmaceutical Tariffs Are Imminent: How Industry is Bracing for Impact
April 16th 2025On April 14, 2025, the Trump Administration launched a national security-driven investigation into pharmaceuticals, a move that will likely result in tariffs being placed on pharmaceutical drugs, ingredients, and other components that are imported from outside of the United States.
